Single-cell spatial analysis of pediatric high-grade glioma reveals a novel population of SPP1+/GPNMB+ myeloid cells with immunosuppressive and tumor-promoting capabilities
Neuro-Oncology Pediatrics · 2025
DOI: 10.1093/neuped/wuaf002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Pediatrics, 2025. Verfasst von Thijs J M van den Broek und 21 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Kinderen Kankervrij, Fight Kids Cancer, Netherlands Organisation for Scientific Research.
Abstract (Originalsprache)
Background
Pediatric-type diffuse high-grade gliomas (pHGGs) are a leading cause of pediatric cancer-related mortality. Although immunotherapy offers a promising treatment avenue, clinical responses in pHGG patients remain limited. A detailed understanding of the tumor immune microenvironment (TIME) is essential for advancing immunotherapeutic strategies.
Methods
We performed single-cell spatial analysis integrating cyclical immunofluorescence imaging and spatial molecular imaging to interrogate the proteomic and transcriptomic landscape of pHGGs. A tissue microarray comprising 32 diagnostic patient-derived pHGG samples was utilized to map the spatial distribution of immune and tumor cells.
Results
Our analyses reveal that the pHGG TIME is predominantly composed of myeloid cells, including brain-resident microglia and monocyte-derived macrophages, with only few T cells. A significant subset of these myeloid cells expresses mesenchymal (MES)-like genes and is positive for SPP1 and GPNMB. Spatial mapping further demonstrated that SPP1+/GPNMB+ myeloid cells localize in close proximity to MES-like tumor cells, and negatively correlate with the location and presence of CD8+ T cells. These cells also express genes related to immunosuppression and epithelial-to-mesenchymal transition, indicating their potential role in establishing an immunosuppressive niche.
Conclusions
Our findings reveal a distinct immune landscape in pHGGs characterized by SPP1+/GPNMB+ myeloid cells which may contribute to the exclusion of CD8+ T cells. This spatially resolved insight identifies these myeloid cells as promising therapeutic targets and provides a rationale for developing novel immunotherapeutic strategies to improve outcomes in pediatric high-grade gliomas.
Förderung
- Stichting Kinderen Kankervrij
- Fight Kids Cancer
- Netherlands Organisation for Scientific Research
Zitieren
APA
Broek, T. J. M. V. D., Hoogendijk, R., Kranendonk, M. E. G., Lammers, J. A. S., Krishnamoorthy, A. L., Ineveld, R. L. V., Molleson, M., Tsvetkov, V. O., Ringnalda, F. C. A., Wetering, M. V. D., Su, Y., Bianco, J. I., Ruiz-Moreno, C., Ries, M. G., Hoving, E. W., Lugt, J. V. D., Akkari, L., Schrijver, D. P., Stunnenberg, H. G., …, & Zomer, A. (2025). Single-cell spatial analysis of pediatric high-grade glioma reveals a novel population of SPP1+/GPNMB+ myeloid cells with immunosuppressive and tumor-promoting capabilities. Neuro-Oncology Pediatrics. https://doi.org/10.1093/neuped/wuaf002
Vancouver
Broek TJMVD, Hoogendijk R, Kranendonk MEG, Lammers JAS, Krishnamoorthy AL, Ineveld RLV, et al. Single-cell spatial analysis of pediatric high-grade glioma reveals a novel population of SPP1+/GPNMB+ myeloid cells with immunosuppressive and tumor-promoting capabilities. Neuro-Oncology Pediatrics. 2025. doi:10.1093/neuped/wuaf002
BibTeX
@article{Broek2025,
author = {Broek, Thijs J M van den and Hoogendijk, Raoull and Kranendonk, Mariëtte E G and Lammers, Julie A S and Krishnamoorthy, Akshaya L and Ineveld, Ravian L van and Molleson, Milo and Tsvetkov, Vasily O and Ringnalda, Femke C A and Wetering, Marc van de and Su, Yan and Bianco, John I and Ruiz-Moreno, Cristian and Ries, Mario G and Hoving, Eelco W and Lugt, Jasper van der and Akkari, Leila and Schrijver, David P and Stunnenberg, Hendrik G and Rios, Anne C and Vuurden, Dannis G van and Zomer, Anoek},
title = {Single-cell spatial analysis of pediatric high-grade glioma reveals a novel population of SPP1+/GPNMB+ myeloid cells with immunosuppressive and tumor-promoting capabilities},
journal = {Neuro-Oncology Pediatrics},
year = {2025},
doi = {10.1093/neuped/wuaf002}
}
EUVIMED